Clinicopathological Study of Autoimmune Hepatitis Cases That Were Difficult to Differentiate from Drug-Induced Liver Injury

Aim: Acute-onset autoimmune hepatitis (AIH) histopathologically presents with features of acute hepatitis and lacks a specific diagnostic method. Also, AIH is often difficult to differentiate from drug-induced liver injury (DILI). We aimed to investigate the final clinical diagnosis of these cases, and compare the clinical, biochemical, and histological characteristics of AIH vs. DILI. Methods: We examined the Digestive Disease Week Japan 2004 (DDW-J) scale scores, AIH scores, clinical data, and pathological findings in 20 patients in whom it was difficult to differentiate autoimmune liver disease from DILI. Results: In cases with a DDW-J scale score of ≥5, there was a good correlation between the final diagnosis and DDW-J scale assessments, but in cases with a DDW-J scale score of ≦4 they did not correlate well. The scores for pathological findings, such as cobblestone hepatocellular change (p = 0.015), interface hepatitis (p = 0.012), and prominent plasma cells in portal areas (p = 0.011), were higher in the AIH group than in the DILI group. Conclusion: This study showed that DDW-J scale was useful for differentiating AIH from DILI in cases with a DDW-J scale score of ≧5. The histologic features of AIH were characterized by cobblestone hepatocellular change, interface hepatitis, and plasma cell infiltration of the portal region.

[1]  S. Kaçar,et al.  Clinical and histological features of idiosyncratic liver injury: Dilemma in diagnosis of autoimmune hepatitis , 2016, Hepatology research : the official journal of the Japan Society of Hepatology.

[2]  Joong-Won Park,et al.  Clinical Characteristics of Patients with Cryptogenic Hepatocellular Carcinoma in a Hepatitis B Virus-Endemic Area , 2015, Liver Cancer.

[3]  Y. Nakanuma,et al.  Comparison of Liver Biopsy Findings with the Digestive Disease Week Japan 2004 Scale for Diagnosis of Drug-Induced Liver Injury , 2015, Mediators of inflammation.

[4]  S. M. de la Monte,et al.  Potential Role of Phosphorylation as a Regulator of Aspartyl-(asparaginyl)-β-hydroxylase: Relevance to Infiltrative Spread of Human Hepatocellular Carcinoma , 2015, Liver Cancer.

[5]  P. Scheuer,et al.  Scheuer's Liver Biopsy Interpretation , 2015 .

[6]  A. Czaja Diagnosis and management of autoimmune hepatitis , 2015, BMJ.

[7]  M. Gershwin,et al.  Emperipolesis Mediated by CD8 T Cells Is a Characteristic Histopathologic Feature of Autoimmune Hepatitis , 2015, Clinical Reviews in Allergy & Immunology.

[8]  Yoshiro Saito,et al.  A detection algorithm for drug‐induced liver injury in medical information databases using the Japanese diagnostic scale and its comparison with the Council for International Organizations of Medical Sciences/the Roussel Uclaf Causality Assessment Method scale , 2014, Pharmacoepidemiology and drug safety.

[9]  C. V. van Nieuwkerk,et al.  Auto immune hepatitis. , 2016, World journal of gastroenterology.

[10]  R. Andrade,et al.  The use of liver biopsy evaluation in discrimination of idiopathic autoimmune hepatitis versus drug‐induced liver injury , 2011, Hepatology.

[11]  J. Talwalkar,et al.  Drug‐induced autoimmune hepatitis: Clinical characteristics and prognosis , 2010, Hepatology.

[12]  J. Lefkowitch Comprar Scheuer's Liver Biopsy Interpretation (Searchable Full Text Online) | Jay H. Lefkowitch | 9780702034107 | Saunders , 2010 .

[13]  Michael P Holt,et al.  Drug-induced liver injury. , 2010, Handbook of experimental pharmacology.

[14]  J. Uetrecht,et al.  Immunoallergic Drug-Induced Liver Injury in Humans , 2009, Seminars in liver disease.

[15]  D. Kleiner,et al.  The Pathology of Drug-Induced Liver Injury , 2009, Seminars in liver disease.

[16]  K. Tajiri,et al.  Practical guidelines for diagnosis and early management of drug-induced liver injury. , 2008, World journal of gastroenterology.

[17]  I. Ng,et al.  Molecular Pathogenesis of Hepatocellular Carcinoma , 2016, Liver Cancer.

[18]  Y. Nakanuma,et al.  Hepatic centrilobular zonal necrosis with positive antinuclear antibody: a unique subtype or early disease of autoimmune hepatitis? , 2007, Human pathology.

[19]  央 日高,et al.  DDW-J2004薬物性肝障害ワークショップのスコアリングに関するvalidity study , 2007 .

[20]  Paul B Watkins,et al.  Drug‐induced liver injury: Summary of a single topic clinical research conference , 2006, Hepatology.

[21]  E. Penner,et al.  Centrilobular necrosis in autoimmune hepatitis: a histological feature associated with acute clinical presentation , 2006, Journal of Clinical Pathology.

[22]  R. Priori,et al.  Autoimmune hepatitis associated with infliximab in a patient with psoriatic arthritis , 2005, Annals of the rheumatic diseases.

[23]  J. Misdraji,et al.  Autoimmune Hepatitis With Centrilobular Necrosis , 2004, The American journal of surgical pathology.

[24]  M. Setti,et al.  Atorvastatin as a trigger of autoimmune hepatitis. , 2004, Journal of hepatology.

[25]  N. Kaplowitz,et al.  Drug-Induced Liver Injury , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  N. Kaplowitz,et al.  Immune-mediated drug-induced liver disease. , 2002, Clinics in liver disease.

[27]  S. Thorgeirsson,et al.  Molecular pathogenesis of human hepatocellular carcinoma , 2002, Nature Genetics.

[28]  P. Schirmacher,et al.  Autoimmune hepatitis and overlap syndromes. , 2002, Clinics in liver disease.

[29]  E. Elias,et al.  Recurrence of autoimmune hepatitis after liver transplantation. , 1999, Transplantation.

[30]  M. Kaplan,et al.  A novel histological lesion in glucocorticoid-responsive chronic hepatitis. , 1997, Gastroenterology.

[31]  H. Nagura,et al.  In situ distribution of enolase isozymes in chronic liver disease. , 1989, The American journal of gastroenterology.

[32]  S. Pocock,et al.  Late results of the Royal Free Hospital prospective controlled trial of prednisolone therapy in hepatitis B surface antigen negative chronic active hepatitis. , 1980, Gut.

[33]  L. Elveback,et al.  Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis. , 1972, Gastroenterology.